Gero
Biotechnology ResearchCalifornia, United States51-200 Employees
Gero is a biotechnology research company headquartered in Palo Alto, California, with a workforce of 51 to 200 employees. It operates at the preclinical stage of AI-driven drug discovery, focusing on age-related diseases. The company uses artificial intelligence to construct clinically relevant disease phenotypes from real-world human data and to identify diseases that share common biological pathways. For these phenotypes, Gero conducts whole-exome sequencing–enabled genetic studies to discover novel targets that may be applicable across multiple indications. Gero maintains a publications page to share its research outputs, accessible at https://gero.ai/publications, and its primary website is https://gero.ai.